Description | PAD (aa 462-477) Antibody (V3S-0324-FY88), mSol2, was developed to specifically target amino acids 462 to 477 of PAD2, showcasing cross-reactivity with PAD2 and PAD4, and exhibiting a high affinity for binding to both PAD2 and PAD4. PAD (aa 629-645) Antibody (V3S-0324-FY89), mSol3, was developed specifically to bind to region 629-645 of PAD4. Our research findings indicate that this antibody exhibits cross-reactivity with PAD2, PAD3 and PAD4, and is capable of binding to both PAD2, PAD3 and PAD4 with high affinity. |
Clonality | Monoclonal |
Host Species | Mouse |
Target Species | Human, Mouse |
Epitope | Amino acids 462-477 |
Isotype | Mouse IgG |
Expression Species | HEK293F or CHO |
Conjugation | None |
Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
Endotoxin | <1 EU/mg |
Purification | Protein G affinity purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
Application | ELISA |
Application Notes | ELISA: 10 μg/mL |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Target | PAD |
Alternative Name | Peptidylarginine deiminase; PAD |
Related pathway | Autophagy |
Research Area | Autophagy |
Related Disease | Autoimmune disease |